Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.87 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.70 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.70 |
| ▸ | MAPT | P10636 | 1/20 | 0.66 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.66 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.65 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.65 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.59 |
| ▸ | NAAA | Q02083 | 1/20 | 0.58 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.55 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.55 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.55 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.55 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.55 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.55 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29866085 | 1.00 | CYP1A2 (0.87) | CYP1A2HDAC1HDAC8MAPTRXFP1 | |
| SCHEMBL31156411 | 1.00 | CYP1A2 (0.87) | CYP1A2HDAC1HDAC8MAPTRXFP1 | |
| SCHEMBL10439522 | 1.00 | CYP1A2 (0.87) | CYP1A2HDAC1HDAC8MAPTRXFP1 | |
| SCHEMBL710798 | 1.00 | CYP1A2 (0.87) | CYP1A2HDAC1HDAC8MAPTRXFP1 | |
| SCHEMBL10439619 | 1.00 | CYP1A2 (0.87) | CYP1A2HDAC1HDAC8MAPTRXFP1 | |
| SCHEMBL10439620 | 1.00 | CYP1A2 (0.87) | CYP1A2HDAC1HDAC8MAPTRXFP1 | |
| SCHEMBL10439755 | 1.00 | CYP1A2 (0.87) | CYP1A2HDAC1HDAC8MAPTRXFP1 | |
| SCHEMBL8434872 | 1.00 | CYP1A2 (0.87) | CYP1A2HDAC1HDAC8MAPTRXFP1 | |
| SCHEMBL2536989 | 1.00 | CYP1A2 (0.87) | CYP1A2HDAC1HDAC8MAPTRXFP1 | |
| SCHEMBL2545033 | 1.00 | CYP1A2 (0.87) | CYP1A2HDAC1HDAC8MAPTRXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0254000-B1 | RAPID DETECTION OF N. GONORRHOEAE WITHOUT CULTURE | MILES INC. (US) | 1991-05-22 | — | — | EP | claimed |
| CN-121801626-A | High-pressure-resistant lubricating sealing grease composition and high-pressure-resistant lubricating sealing grease | 金鹰润滑材料(金湖)有限公司 | 2026-04-07 | — | — | CN | disclosed |
| EP-4294878-A1 | COATING COMPOSITION COMPRISING A PIGMENT PASTE COMPRISING AN ORGANIC PIGMENT AND AN ARYL-MODIFIED BRANCHED REACTION PRODUCT | BASF Coatings GmbH (DE) | 2023-12-27 | — | — | EP | disclosed |
| WO-2022175076-A1 | COATING COMPOSITION COMPRISING A PIGMENT PASTE COMPRISING AN ORGANIC PIGMENT AND AN ARYL-MODIFIED BRANCHED REACTION PRODUCT | BASF COATINGS GMBH (DE) | 2022-08-25 | — | — | WO | disclosed |
| US-20190106592-A1 | HYPERBRANCHED POLYMERS FOR ORGANIC PIGMENT DISPERSIONS AND WATER-SENSITIVE PIGMENTS | BASF COATINGS GMBH (DE) | 2019-04-11 | — | — | US | disclosed |
| EP-1865049-B1 | CLEANING AGENT FOR THERMOSTATIC CHAMBERS | WAKO PURE CHEM IND LTD (JP) | 2014-08-06 | — | — | EP | disclosed |
| US-8669375-B2 | Process for producing ester compound | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2014-03-11 | — | — | US | disclosed |
| US-20130066070-A1 | PROCESS FOR PRODUCING ESTER COMPOUND | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2013-03-14 | — | — | US | disclosed |
| US-8318964-B2 | Process for producing ester compound | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-11-27 | — | — | US | disclosed |
| US-20120288796-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2012-11-15 | — | — | US | disclosed |
| CN-1622943-A | Heterocyclic onium salt | WAKO PURE CHEM IND LTD (JP) | 2005-06-01 | — | — | CN | disclosed |
| CN-1578766-A | Hybrid onium salt | WAKO PURE CHEM IND LTD (JP) | 2005-02-09 | — | — | CN | disclosed |
| US-20050020710-A1 | Hybrid onium salt | WAKO PURE CHEMICALS INDUSTRIES, LTD. (JP) | 2005-01-27 | — | — | US | disclosed |
| EP-1481973-A1 | HETEROCYCLE-BEARING ONIUM SALTS | Wako Pure Chemical Industries, Ltd. (JP) | 2004-12-01 | — | — | EP | disclosed |
| EP-1443042-A1 | HYBRID ONIUM SALT | Wako Pure Chemical Industries, Ltd. (JP) | 2004-08-04 | — | — | EP | disclosed |
| US-6723483-B1 | Sulfonium salt compounds | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2004-04-20 | — | — | US | disclosed |
| EP-1238969-A2 | Sulfonium salt compounds | Wako Pure Chemical Industries, Ltd. (JP) | 2002-09-11 | — | — | EP | disclosed |
| CN-1302799-A | Sulfonium salt compound | WAKO PURE CHEM IND LTD (JP) | 2001-07-11 | — | — | CN | disclosed |
| EP-1113005-A1 | Sulfonium salt compounds | Wako Pure Chemical Industries, Ltd. (JP) | 2001-07-04 | — | — | EP | disclosed |
| EP-0382990-A1 | Strains of bacillus thuringiensis | PLANT GENETIC SYSTEMS, N.V. (BE) | 1990-08-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130066070-A1 | PROCESS FOR PRODUCING ESTER COMPOUND | ADH1C, ADH5, ADH1A | CYP1A2 440/4885HDAC1 1470/4885HDAC8 1767/4885 |
| US-20190106592-A1 | HYPERBRANCHED POLYMERS FOR ORGANIC PIGMENT DISPERSIONS AND WATER-SENSITIVE PIGMENTS | TYR, PAH, AHR | CYP1A2 81/4885HDAC1 4280/4885HDAC8 3579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.